Combining human thinking with computer tactics: the future of medicinal chemistry?
Computational chemical biology: the intersection between chemical biology and computational chemistry
Spheroids and high-throughput screening: a method for identifying anticancer therapeutics
Perspective: the benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions
New computational approach identifies not so novel drugs to tackle ovarian cancer
The potential role of in silico approaches to identify novel bioactive molecules from natural resources
Lead to Hit, rather than Hit to Lead: why medicinal chemists at GlaxoSmithKline are working backwards
A novel 3D visualization tool: a promising workflow for mapping the lung’s chemical and microbial make-up?